ANGO — Angiodynamics Cashflow Statement
0.000.00%
Last trade - 00:00
- $250.74m
- $172.29m
- $338.75m
- 68
- 54
- 47
- 57
2019 May 31st | 2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 61.3 | -167 | -31.5 | -26.5 | -52.4 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | -45.9 | 159 | 25.5 | 14.8 | 31 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1.26 | -28.5 | 9.07 | -21 | -7.03 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Cash from Operating Activities | 37.4 | -14.6 | 24.1 | -7.19 | 0.078 |
Capital Expenditures | -3.12 | -7.58 | -5.19 | -4.3 | -4.35 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 85.7 | -55.8 | -8.52 | -15 | -5.39 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale/Maturity of Investment | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 82.6 | -63.3 | -13.7 | -19.3 | -9.75 |
Financing Cash Flow Items | -8.1 | -1.98 | 0 | 0 | -0.751 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 33.9 | -95.2 | -17 | 7.68 | 25.4 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 154 | -173 | -6.27 | -19.3 | 15.8 |